Haven't used Ctx Platforms yet?
Ask AI

Ask AI about Ctx Platforms

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Maickel Abdou
Reviews 1

Ctx Platforms has been a game-changer for our business. Their innovative solutions have helped us streamline our processes and increase productivity. The team is responsive, and their expertise is evident in the results they deliver.

Hunter Ziesing
Reviews 1

The services provided by Ctx Platforms are truly exceptional. The team is professional, knowledgeable, and always ready to assist. I am impressed with their attention to detail and commitment to delivering top-notch results. It has been a pleasure working with them.

Sue Carlson
Reviews 1

I had an awesome experience working with Ctx Platforms. Their solutions exceeded my expectations and helped me achieve my goals. The team was responsive and professional throughout the process. I would highly recommend their services.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="ctx-platforms-com" data-lang="en"></div>
More widgets

About Ctx Platforms

Ctx Platforms is a biotech company developing a targeted protein delivery system for diagnosing and treating cancer. CTX-Platforms is launching a cancer-targeting peptide platform based on a patent-pending synthetic molecule derived from scorpion venom, which can easily penetrate the blood-brain barrier as well as solid tumors outside the central nervous system.

The company is developing specific proteins to serve as bio carriers. These proteins are derived from various scorpion venoms, expressing unique characteristics, namely, selective affinity to cancer tissues, high stability, and effective penetrability to the blood-brain barrier (BBB). It holds intellectual property for a synthetic peptide based on a natural molecule from scorpion venom. The peptide has selective affinity to cancer cells, it penetrates the BBB and enables its use in therapy and diagnostics.